Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Total Current Liabilities (2016 - 2025)

Ocular Therapeutix (OCUL) has 13 years of Total Current Liabilities data on record, last reported at $50.8 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 22.86% year-over-year to $50.8 million; the TTM value through Dec 2025 reached $50.8 million, up 22.86%, while the annual FY2025 figure was $50.8 million, 22.86% up from the prior year.
  • Total Current Liabilities reached $50.8 million in Q4 2025 per OCUL's latest filing, up from $49.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $50.8 million in Q4 2025 and bottomed at $21.6 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $32.8 million, with a median of $30.7 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 146.91% in 2021, then fell 18.23% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $26.3 million in 2021, then rose by 19.2% to $31.4 million in 2022, then rose by 11.15% to $34.9 million in 2023, then grew by 18.51% to $41.4 million in 2024, then grew by 22.86% to $50.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $50.8 million in Q4 2025, $49.3 million in Q3 2025, and $42.9 million in Q2 2025.